Real-time enrollment status for this choroidal melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:29 PM UTC
| NCT Number | NCT06007690 |
| Recruiting Status | Recruiting |
| Condition | Choroidal Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Aura Biosciences |
| Last Updated on CT.gov | March 2, 2026 (Mar 2, 2026) |
As of July 18, 2026: Clinical trial NCT06007690 is currently recruiting participants. This phase3 study for choroidal melanoma is actively seeking new participants at 36 locations across the United States. The study is sponsored by Aura Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06007690 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06007690 was last updated Mar 2, 2026 (March 2, 2026). HelloStudys verifies this status automatically.